(Q43924367)

reason for preferred rank

28 November 2017

title

Anti?tumor necrosis factor therapy abrogates autoimmune demyelination (English)

1 reference

https://api.crossref.org/works/10.1002/ANA.410300510

8 November 2022

Anti-tumor necrosis factor therapy abrogates autoimmune demyelination (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1722388

8 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1722388

8 November 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300510

8 November 2022

2

Raine CS

1 reference

28 November 2017

1

K. Selmaj

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1722388

8 November 2022

3

A. H. Cross

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1722388

8 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1722388

8 November 2022

publication date

1 November 1991

1 reference

full work available at URL

28 November 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fana.410300510

1 reference

https://api.crossref.org/works/10.1002/ANA.410300510

https://onlinelibrary.wiley.com/doi/full/10.1002/ana.410300510

8 November 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300510

8 November 2022

1 reference

28 November 2017

volume

30

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

694-700

1 reference

Tumour necrosis factor and lymphotoxin genes map close to H–2D in the mouse major histocompatibility complex

28 November 2017

cites work

4

1 reference

https://api.crossref.org/works/10.1002/ANA.410300510

Tumor necrosis factor identified in multiple sclerosis brain

8 November 2022

5

1 reference

https://api.crossref.org/works/10.1002/ANA.410300510

Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions

8 November 2022

6

1 reference

https://api.crossref.org/works/10.1002/ANA.410300510

Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

8 November 2022

7

1 reference

https://api.crossref.org/works/10.1002/ANA.410300510

An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

8 November 2022

9

1 reference

https://api.crossref.org/works/10.1002/ANA.410300510

An analysis of the role of tumor necrosis factor in the phenotypic expression of actively induced experimental allergic orchitis and experimental allergic encephalomyelitis

8 November 2022

10

1 reference

https://api.crossref.org/works/10.1002/ANA.410300510

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

8 November 2022

12

1 reference

https://api.crossref.org/works/10.1002/ANA.410300510

Comparison of in vitro cell cytotoxic assays for tumor necrosis factor

8 November 2022

14

1 reference

https://api.crossref.org/works/10.1002/ANA.410300510

American Journal of Physiology

8 November 2022

18

134

551

Cavender

1989

1 reference

https://api.crossref.org/works/10.1002/ANA.410300510

Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro

8 November 2022

19

1 reference

https://api.crossref.org/works/10.1002/ANA.410300510

Effects of tumor necrosis factor on the interferon-gamma-induced major histocompatibility complex class II antigen expression by human endothelial cells

8 November 2022

20

1 reference

https://api.crossref.org/works/10.1002/ANA.410300510

Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody

8 November 2022

29

1 reference

https://api.crossref.org/works/10.1002/ANA.410300510

Identification and characterization of a membrane-bound cytotoxin of murine cytolytic lymphocytes that is related to tumor necrosis factor/cachectin

8 November 2022

30

1 reference

https://api.crossref.org/works/10.1002/ANA.410300510

A novel addition to the T cell repertory. Cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells

8 November 2022

31

1 reference

https://api.crossref.org/works/10.1002/ANA.410300510

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF

8 November 2022

32

1 reference

https://api.crossref.org/works/10.1002/ANA.410300510

Effect of tumor necrosis factor alpha on mitogen-activated human B cells

8 November 2022

34

1 reference

https://api.crossref.org/works/10.1002/ANA.410300510

Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha

8 November 2022

35

1 reference

https://api.crossref.org/works/10.1002/ANA.410300510

Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system

8 November 2022

36

1 reference

https://api.crossref.org/works/10.1002/ANA.410300510

8 November 2022

Identifiers

1 reference

28 November 2017

1 reference